X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE CIPLA TTK HEALTHCARE/
CIPLA
 
P/E (TTM) x 50.2 45.0 111.7% View Chart
P/BV x 9.2 3.9 240.0% View Chart
Dividend Yield % 0.3 0.3 94.3%  

Financials

 TTK HEALTHCARE   CIPLA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
CIPLA
Mar-17
TTK HEALTHCARE/
CIPLA
5-Yr Chart
Click to enlarge
High Rs663622 106.7%   
Low Rs399458 87.1%   
Sales per share (Unadj.) Rs535.6181.9 294.5%  
Earnings per share (Unadj.) Rs15.912.9 123.9%  
Cash flow per share (Unadj.) Rs20.029.3 68.3%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.80.4 203.4%  
Book value per share (Unadj.) Rs137.6155.7 88.4%  
Shares outstanding (eoy) m7.77804.51 1.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.03.0 33.4%   
Avg P/E ratio x33.342.0 79.4%  
P/CF ratio (eoy) x26.518.4 144.0%  
Price / Book Value ratio x3.93.5 111.3%  
Dividend payout %25.115.5 161.4%   
Avg Mkt Cap Rs m4,127434,516 0.9%   
No. of employees `0001.723.0 7.4%   
Total wages/salary Rs m60726,338 2.3%   
Avg. sales/employee Rs Th2,436.76,349.1 38.4%   
Avg. wages/employee Rs Th355.21,143.0 31.1%   
Avg. net profit/employee Rs Th72.5449.3 16.1%   
INCOME DATA
Net Sales Rs m4,162146,302 2.8%  
Other income Rs m612,287 2.7%   
Total revenues Rs m4,223148,589 2.8%   
Gross profit Rs m19724,758 0.8%  
Depreciation Rs m3213,229 0.2%   
Interest Rs m301,594 1.9%   
Profit before tax Rs m19712,222 1.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,798 4.0%   
Profit after tax Rs m12410,354 1.2%  
Gross profit margin %4.716.9 28.0%  
Effective tax rate %37.014.7 251.6%   
Net profit margin %3.07.1 42.1%  
BALANCE SHEET DATA
Current assets Rs m1,62987,370 1.9%   
Current liabilities Rs m1,05833,081 3.2%   
Net working cap to sales %13.737.1 37.0%  
Current ratio x1.52.6 58.3%  
Inventory Days Days3087 34.2%  
Debtors Days Days3462 53.9%  
Net fixed assets Rs m556111,567 0.5%   
Share capital Rs m781,609 4.8%   
"Free" reserves Rs m878123,645 0.7%   
Net worth Rs m1,069125,254 0.9%   
Long term debt Rs m15936,454 0.4%   
Total assets Rs m2,399209,532 1.1%  
Interest coverage x7.68.7 87.4%   
Debt to equity ratio x0.10.3 51.0%  
Sales to assets ratio x1.70.7 248.4%   
Return on assets %6.45.7 112.4%  
Return on equity %11.68.3 140.2%  
Return on capital %18.58.5 217.1%  
Exports to sales %0.834.2 2.3%   
Imports to sales %1.48.3 16.8%   
Exports (fob) Rs m3350,050 0.1%   
Imports (cif) Rs m5812,203 0.5%   
Fx inflow Rs m3351,066 0.1%   
Fx outflow Rs m6317,678 0.4%   
Net fx Rs m-3033,388 -0.1%   
CASH FLOW
From Operations Rs m12723,824 0.5%  
From Investments Rs m-146-13,127 1.1%  
From Financial Activity Rs m22-13,239 -0.2%  
Net Cashflow Rs m3-2,478 -0.1%  

Share Holding

Indian Promoters % 65.4 16.0 408.8%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 3.7 12.2 30.3%  
FIIs % 5.2 23.7 21.9%  
ADR/GDR % 0.0 1.1 -  
Free float % 25.8 26.2 98.5%  
Shareholders   12,723 161,166 7.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALEMBIC LTD  SUN PHARMA  PFIZER  GLENMARK PHARMA  SHASUN PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 19, 2018 03:37 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS